Skip to main content
Caplight Logo









Pharmazz, Inc.

Pharmazz, Inc.

Private
Willowbrook, IllinoisHealthcare & Life Scienceshttps://pharmazz.com/

Last Round

Seed Round

Jul 28, 2026

Est. Valuation

$110.13M

Total Funding Raised

$40.7M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Pharmazz, Inc. is a biopharmaceutical company that develops and commercializes novel therapeutics to treat patients in critical care.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Non-AI

Keywords

biopharmaceuticalcritical care medicinesmall molecule therapeuticsclinical developmentdrug discoveryhypovolemic shockischemic strokebiotechclinical trialspharmaceutical licensingdrug commercializationregulatory advisorypharmaresuscitative agentneurovascular agent

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Pharmazz, Inc. Comparables

Compare Pharmazz, Inc. with similar companies based on industry and business-model similarity.

Pharmazz, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Remedy Pharmaceuticals
78%
Prolong Pharmaceuticals, LLC
77%
Sun Pharma
76%

Pharmazz, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Seed RoundJul 28, 2026
VC RoundJun 11, 2025
Convertible DebtAug 21, 2024
Series AMay 23, 2024
Seed RoundFeb 16, 2024
Grant
Aug 20, 2017

Key People

Founding team and executive leadership

Sunil Gulati

Chief Operating Officer

Executive Team

Pharmazz, Inc. Investors

Notable investors and investment history

Pharmazz, Inc. investors
InvestorRounds
NIH RADxGrant
National Heart, Lung, and Blood InstituteGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 28, 2026

    $250K raised in Seed Round.

  • Jul 13, 2026

    Open roles increased to 7, 3.5x the trailing average.

Pharmazz, Inc. Filings

Explore SEC and related filing metadata, where available.

Pharmazz, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Pharmazz, Inc.'s valuation, stock price, and market status.

Is Pharmazz, Inc. a public or private company?

Pharmazz, Inc. is a private company.

What is the current stock price of Pharmazz, Inc.?

Pharmazz, Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is Pharmazz, Inc. worth (valuation)?

Valuation information for Pharmazz, Inc. is not publicly available.

Can I buy Pharmazz, Inc. stock?

Pharmazz, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Pharmazz, Inc.'s last funding round?

Pharmazz, Inc.'s most recent funding round was Seed Round on February 16, 2024.

Who are the main investors in Pharmazz, Inc.?

Investor information for Pharmazz, Inc. is not publicly disclosed.

Will Pharmazz, Inc. IPO soon?

No public IPO plans have been announced for Pharmazz, Inc..

How can I track Pharmazz, Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Pharmazz, Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersWillowbrook, Illinois
Employee Range43
Year Founded2010
Last FundingJul 28, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?